307 related articles for article (PubMed ID: 27709652)
21. Plasma EBV microRNAs in paediatric renal transplant recipients.
Hassan J; Dean J; De Gascun CF; Riordan M; Sweeney C; Connell J; Awan A
J Nephrol; 2018 Jun; 31(3):445-451. PubMed ID: 29185211
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus microRNA miR-BART2-5p accelerates nasopharyngeal carcinoma metastasis by suppressing RNase Ⅲ endonuclease DICER1.
Wu Y; Zhang X; Liu C; Li Z; Wen Y; Zheng R; Xu C; Tian J; Wei L; Wang J; Yan Q; Zheng X; Ma J
J Biol Chem; 2023 Sep; 299(9):105082. PubMed ID: 37495108
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA profiling of Epstein-Barr virus-associated NK/T-cell lymphomas by deep sequencing.
Motsch N; Alles J; Imig J; Zhu J; Barth S; Reineke T; Tinguely M; Cogliatti S; Dueck A; Meister G; Renner C; Grässer FA
PLoS One; 2012; 7(8):e42193. PubMed ID: 22870299
[TBL] [Abstract][Full Text] [Related]
24. Expression of CD70 in nasal natural killer/T cell lymphoma cell lines and patients; its role for cell proliferation through binding to soluble CD27.
Yoshino K; Kishibe K; Nagato T; Ueda S; Komabayashi Y; Takahara M; Harabuchi Y
Br J Haematol; 2013 Feb; 160(3):331-42. PubMed ID: 23206232
[TBL] [Abstract][Full Text] [Related]
25. Conserved sequences of BART and BHRF regions encoding viral microRNAs in Epstein-Barr virus-associated lymphoma.
Sunagawa K; Hishima T; Fukumoto H; Hasegawa H; Katano H
BMC Res Notes; 2017 Jul; 10(1):279. PubMed ID: 28705173
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus BART9 miRNA modulates LMP1 levels and affects growth rate of nasal NK T cell lymphomas.
Ramakrishnan R; Donahue H; Garcia D; Tan J; Shimizu N; Rice AP; Ling PD
PLoS One; 2011; 6(11):e27271. PubMed ID: 22102884
[TBL] [Abstract][Full Text] [Related]
27. The identification of up-regulated ebv-miR-BHRF1-2-5p targeting MALT1 and ebv-miR-BHRF1-3 in the circulation of patients with multiple sclerosis.
Wang YF; He DD; Liang HW; Yang D; Yue H; Zhang XM; Wang R; Li B; Yang HX; Liu Y; Chen Y; Duan YX; Zhang CY; Chen X; Fu J
Clin Exp Immunol; 2017 Jul; 189(1):120-126. PubMed ID: 28253538
[TBL] [Abstract][Full Text] [Related]
28. An Unusual Case of Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type Masquerading as Dacryocystitis and Sinusitis.
Eze AN; Kalejaiye AO
Ear Nose Throat J; 2023 Mar; 102(3):NP114-NP118. PubMed ID: 33559497
[TBL] [Abstract][Full Text] [Related]
29. CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma.
Kumai T; Nagato T; Kobayashi H; Komabayashi Y; Ueda S; Kishibe K; Ohkuri T; Takahara M; Celis E; Harabuchi Y
Cancer Immunol Immunother; 2015 Jun; 64(6):697-705. PubMed ID: 25754123
[TBL] [Abstract][Full Text] [Related]
30. Clonal deleted latent membrane protein 1 variants of Epstein-Barr virus are predominant in European extranodal NK/T lymphomas and disappear during successful treatment.
Halabi MA; Jaccard A; Moulinas R; Bahri R; Al Mouhammad H; Mammari N; Feuillard J; Ranger-Rogez S
Int J Cancer; 2016 Aug; 139(4):793-802. PubMed ID: 27061907
[TBL] [Abstract][Full Text] [Related]
31. Series of extranodal natural killer/T-cell lymphoma, nasal type, with periorbital involvement.
Termote K; Dierickx D; Verhoef G; Jorissen M; Tousseyn T; Mombaerts I
Orbit; 2014 Aug; 33(4):245-51. PubMed ID: 24831171
[TBL] [Abstract][Full Text] [Related]
32. Circulation EBV Mir-Bart-7 Relating to Clinical Manifestation in Nasopharyngeal Carcinoma.
Wardana T; Gunawan L; Herawati C; Oktriani R; Anwar S; Astuti I; Aryandono T; Mubarika S
Asian Pac J Cancer Prev; 2020 Sep; 21(9):2777-2782. PubMed ID: 32986380
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus-encoded miR-BART5-5p upregulates PD-L1 through PIAS3/pSTAT3 modulation, worsening clinical outcomes of PD-L1-positive gastric carcinomas.
Yoon CJ; Chang MS; Kim DH; Kim W; Koo BK; Yun SC; Kim SH; Kim YS; Woo JH
Gastric Cancer; 2020 Sep; 23(5):780-795. PubMed ID: 32206940
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr Virus Infection of Cell Lines Derived from Diffuse Large B-Cell Lymphomas Alters MicroRNA Loading of the Ago2 Complex.
Ayoubian H; Ludwig N; Fehlmann T; Menegatti J; Gröger L; Anastasiadou E; Trivedi P; Keller A; Meese E; Grässer FA
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429351
[TBL] [Abstract][Full Text] [Related]
35. Nasal natural killer/T-cell lymphoma and its association with type "i"/XhoI loss strain Epstein-Barr virus in Chile.
Cabrera ME; Eizuru Y; Itoh T; Koriyama C; Tashiro Y; Ding S; Rey S; Akiba S; Corvalan A
J Clin Pathol; 2007 Jun; 60(6):656-60. PubMed ID: 16775124
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis and management of extranodal NK/T cell lymphoma nasal type.
Tse E; Kwong YL
Expert Rev Hematol; 2016 Sep; 9(9):861-71. PubMed ID: 27347812
[TBL] [Abstract][Full Text] [Related]
37. Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: Basic Science and Clinical Progress.
Harabuchi Y; Takahara M; Kishibe K; Nagato T; Kumai T
Front Pediatr; 2019; 7():141. PubMed ID: 31041299
[TBL] [Abstract][Full Text] [Related]
38. Serum EBV EA-IgA and VCA-IgA antibodies can be used for risk group stratification and prognostic prediction in extranodal NK/T cell lymphoma: 24-year experience at a single institution.
Huang Y; Rao H; Yan S; Wang F; Wu Q; Feng Y; Zhang Y
Ann Hematol; 2017 Aug; 96(8):1331-1342. PubMed ID: 28550598
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr Virus miRNA BART2-5p Promotes Metastasis of Nasopharyngeal Carcinoma by Suppressing RND3.
Jiang C; Li L; Xiang YQ; Lung ML; Zeng T; Lu J; Tsao SW; Zeng MS; Yun JP; Kwong DLW; Guan XY
Cancer Res; 2020 May; 80(10):1957-1969. PubMed ID: 32060148
[TBL] [Abstract][Full Text] [Related]
40. Combination of Gemcitabine and Thymosin alpha 1 exhibit a better anti-tumor effect on nasal natural killer/T-cell lymphoma.
Chen M; Jiang Y; Cai X; Lu X; Chao H
Int Immunopharmacol; 2021 Sep; 98():107829. PubMed ID: 34119916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
